Impacting the Disposal of Unused Opioid

NCT ID: NCT04044105

Last Updated: 2021-08-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

563 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the rates of proper opioid disposal in patients receiving an educational brochure compared to an automated text message delivered directly to patients' cell phones alongside the brochure, compared to no education on the subject.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Opioids are used to treat acute pain after surgery, but can lead to misuse and abuse. Very few patients properly dispose of unused opioids and the majority of opioids are stored in the home in unlocked containers as opposed to being properly disposed of. Improper disposal of opioid medications is a concern due to the potential for nonmedical use and has the potential to cause injury or death for patients and their family members that can access the medications. The purpose of this study is to compare the rates of proper opioid disposal in patients receiving an educational brochure compared to an automated text message delivered directly to patients' cell phones alongside the brochure, compared to no education on the subject. There is evidence that an educational brochure significantly increases proper disposal rates, albeit only to about 25%. The goal of this study is to evaluate the impact of an educational pamphlet on proper opioid disposal in the total joint arthoplasty population, and to see if the addition of a text messaging system can increase further increase proper disposal rates.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Use and Disposal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Education

Patients in this arm receive no education regarding how to dispose of their opiate medication

Group Type NO_INTERVENTION

No interventions assigned to this group

Pamphlet education

Patients receive an educational pamphlet only, to be given at the preoperative teaching class, prior to their standard 3-week postoperative clinic appointment, and prior to their standard 6-week postoperative clinic appointment.

Group Type EXPERIMENTAL

Pamphlet education

Intervention Type OTHER

Patients receive an educational intervention explaining proper opioid disposal

Pamphlet education + texts

Patients receive an educational pamphlet, to be given at the preoperative teaching class, prior to their standard 3-week postoperative clinic appointment, and prior to their standard 6-week postoperative clinic appointment. In addition, 3 automated text messages sent at those same time points.

Group Type EXPERIMENTAL

Pamphlet education + texts

Intervention Type OTHER

Patients receive an educational intervention and text message explaining proper opioid disposal

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pamphlet education

Patients receive an educational intervention explaining proper opioid disposal

Intervention Type OTHER

Pamphlet education + texts

Patients receive an educational intervention and text message explaining proper opioid disposal

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patient undergoing primary total hip or knee arthroplasty
* Age ≥18 years old

Exclusion Criteria

* Patients allergic to oxycodone
* Patients consuming opioids during the 4 weeks prior to surgery
* Patients with a history of opioid dependence
* Patients undergoing revision total knee or hip arthroplasty
* Non-English speaking patients
* Age \<18 years old
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rush University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Craig J Della Valle, MD

Professor of Orthopaedic Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Craig Della Valle, MD

Role: PRINCIPAL_INVESTIGATOR

Rush

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18092505

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ACL-R Opioid Sparing Study
NCT06561035 ENROLLING_BY_INVITATION PHASE3
Acetaminophen (APAP) +/- Oxycodone
NCT04122443 COMPLETED PHASE4
OLP to Manage Pain in TJA: A Feasibility Study
NCT04883983 WITHDRAWN EARLY_PHASE1